141 related articles for article (PubMed ID: 35460302)
21. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
[TBL] [Abstract][Full Text] [Related]
22. Phenotype variability in patients carrying KCNJ2 mutations.
Kimura H; Zhou J; Kawamura M; Itoh H; Mizusawa Y; Ding WG; Wu J; Ohno S; Makiyama T; Miyamoto A; Naiki N; Wang Q; Xie Y; Suzuki T; Tateno S; Nakamura Y; Zang WJ; Ito M; Matsuura H; Horie M
Circ Cardiovasc Genet; 2012 Jun; 5(3):344-53. PubMed ID: 22589293
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of a double-point mutation in the KCNJ2 gene identified in a family with Andersen-Tawil syndrome.
Fukumura S; Yamauchi K; Kawanabe A; Yamamoto A; Nakaza M; Kubota T; Kato S; Sasaki R; Okamura Y; Takahashi MP
J Neurol Sci; 2019 Dec; 407():116521. PubMed ID: 31669729
[TBL] [Abstract][Full Text] [Related]
24. Andersen-Tawil Syndrome: A Comprehensive Review.
Pérez-Riera AR; Barbosa-Barros R; Samesina N; Pastore CA; Scanavacca M; Daminello-Raimundo R; de Abreu LC; Nikus K; Brugada P
Cardiol Rev; 2021 Jul-Aug 01; 29(4):165-177. PubMed ID: 32947483
[TBL] [Abstract][Full Text] [Related]
25. [QTU pattern in a patient with the Anderson-Tawil syndrome].
Ciurzyński M; Bienias P; Kostera-Pruszczyk A; Pruszczyk P
Kardiol Pol; 2010 Mar; 68(3):339-41; discussion 342. PubMed ID: 20411461
[TBL] [Abstract][Full Text] [Related]
26. Andersen-Tawil Syndrome With Novel Mutation in
Yim J; Kim KB; Kim M; Lee GD; Kim M
Front Pediatr; 2021; 9():790075. PubMed ID: 35174115
[TBL] [Abstract][Full Text] [Related]
27. Identification of the KCNJ2 Mutation in a Korean Family with Andersen-Tawil Syndrome and Developmental Delay.
Kim NR; Jang JH; Jeon GW; Cho EH; Sin JB
Ann Clin Lab Sci; 2016; 46(1):110-3. PubMed ID: 26927354
[TBL] [Abstract][Full Text] [Related]
28. Marked reduction in paralytic attacks in a patient with Andersen-Tawil syndrome switched from acetazolamide to dichlorphenamide.
Gupta A; Iyadurai S; Roggenbuck J; LoRusso S
Neuromuscul Disord; 2021 Jul; 31(7):656-659. PubMed ID: 34078557
[TBL] [Abstract][Full Text] [Related]
29. Compound heterozygous mutations in
Polyak ME; Shestak A; Podolyak D; Zaklyazminskaya E
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843460
[TBL] [Abstract][Full Text] [Related]
30. Coexistence of Andersen-Tawil Syndrome with Polymorphisms in hERG1 Gene (K897T) and SCN5A Gene (H558R) in One Family.
Jagodzińska M; Szperl M; Ponińska J; Kosiec A; Gajda R; Kukla P; Biernacka EK
Ann Noninvasive Electrocardiol; 2016 Mar; 21(2):189-95. PubMed ID: 26109178
[TBL] [Abstract][Full Text] [Related]
31. The clinical and genetic heterogeneity analysis of five families with primary periodic paralysis.
Wang Q; Zhao Z; Shen H; Bing Q; Li N; Hu J
Channels (Austin); 2021 Dec; 15(1):20-30. PubMed ID: 33345742
[TBL] [Abstract][Full Text] [Related]
32. A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1.
Kokunai Y; Nakata T; Furuta M; Sakata S; Kimura H; Aiba T; Yoshinaga M; Osaki Y; Nakamori M; Itoh H; Sato T; Kubota T; Kadota K; Shindo K; Mochizuki H; Shimizu W; Horie M; Okamura Y; Ohno K; Takahashi MP
Neurology; 2014 Mar; 82(12):1058-64. PubMed ID: 24574546
[TBL] [Abstract][Full Text] [Related]
33. Mutations of KCNJ2 gene associated with Andersen-Tawil syndrome in Korean families.
Choi BO; Kim J; Suh BC; Yu JS; Sunwoo IN; Kim SJ; Kim GH; Chung KW
J Hum Genet; 2007; 52(3):280-283. PubMed ID: 17211524
[TBL] [Abstract][Full Text] [Related]
34. A case report of Andersen-Tawil syndrome misdiagnosed with myodystrophy.
Zhao X; Zu H; Yao K
Front Neurol; 2023; 14():1170693. PubMed ID: 37456645
[TBL] [Abstract][Full Text] [Related]
35. Kir 2.1 channelopathies: the Andersen-Tawil syndrome.
Tristani-Firouzi M; Etheridge SP
Pflugers Arch; 2010 Jul; 460(2):289-94. PubMed ID: 20306271
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
Al-Ghamdi F; Darras BT; Ghosh PS
Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
[TBL] [Abstract][Full Text] [Related]
37. Identification and functional characterisation of a novel KCNJ2 mutation, Val302del, causing Andersen-Tawil syndrome.
Ördög B; Hategan L; Kovács M; Seprényi G; Kohajda Z; Nagy I; Hegedűs Z; Környei L; Jost N; Katona M; Szekeres M; Forster T; Papp JG; Varró A; Sepp R
Can J Physiol Pharmacol; 2015 Jul; 93(7):569-75. PubMed ID: 26103554
[TBL] [Abstract][Full Text] [Related]
38. [Andersen syndrome: a particular form of paralysis with cardiac dysrhythmia].
Pouget J; Philip N; Faugere G; Pellissier JF
Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S38-42. PubMed ID: 15269659
[TBL] [Abstract][Full Text] [Related]
39. Andersen-Tawil syndrome: definition of a neurocognitive phenotype.
Yoon G; Quitania L; Kramer JH; Fu YH; Miller BL; Ptácek LJ
Neurology; 2006 Jun; 66(11):1703-10. PubMed ID: 16769944
[TBL] [Abstract][Full Text] [Related]
40. Molecular stratification of arrhythmogenic mechanisms in the Andersen Tawil syndrome.
Moreno-Manuel AI; Gutiérrez LK; Vera-Pedrosa ML; Cruz FM; Bermúdez-Jiménez FJ; Martínez-Carrascoso I; Sánchez-Pérez P; Macías Á; Jalife J
Cardiovasc Res; 2023 May; 119(4):919-932. PubMed ID: 35892314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
